Leukemia inhibitory factor in human reproductionLASS, Amir; WEISER, Weishui; MUNAFO, Alain et al.Fertility and sterility. 2001, Vol 76, Num 6, pp 1091-1096, issn 0015-0282Article

Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropinsLASS, Amir; VASSILIEV, Anatole; DECOSTERD, Genevieve et al.Fertility and sterility. 2002, Vol 78, Num 2, pp 265-269, issn 0015-0282Article

Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadismBOULOUX, Pierre; WARNE, David W; LOUMAYE, Ernest et al.Fertility and sterility. 2002, Vol 77, Num 2, pp 270-273, issn 0015-0282Conference Paper

Kit Ligand and the Somatostatin Receptor Antagonist, BIM-23627, Stimulate in Vitro Resting Follicle Growth in the Neonatal Mouse OvaryGOUGEON, Alain; DELANGLE, Aurélien; AROUCHE, Nassim et al.Endocrinology (Philadelphia). 2010, Vol 151, Num 3, pp 1299-1309, issn 0013-7227, 11 p.Article

Evaluation of Estrogen Treatment in an Immunodeficient Mouse Endometriosis ModelCOLETTE, Sébastien; DEFRERE, Sylvie; LOUSSE, Jean-Christophe et al.Gynecologic and obstetric investigation. 2009, Vol 68, Num 4, pp 262-268, issn 0378-7346, 7 p.Article

Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in world health organization type I and type II anovulationLOUMAYE, Ernest; ENGRAND, Patrick; SHOHAM, Zeev et al.Human reproduction (Oxford. Print). 2003, Vol 18, Num 2, pp 314-322, issn 0268-1161, 9 p.Article

A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropinsMARCI, Roberto; CHANSON, Alain; GERMOND, Marc et al.Fertility and sterility. 2001, Vol 75, Num 6, pp 1131-1135, issn 0015-0282Article

Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatmentBECKERS, Nicole G. M; MACKLON, Nicholas S; EIJKEMANS, Marinus J et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 9, pp 4186-4192, issn 0021-972X, 7 p.Article